• Korean Journal of Biological Psychiatry
• /
• v.23 no.3
• /
• pp.80-88
• /
• 2016

Vascular dementia is a very frequent form of dementia. Debates over classification and diagnostic criteria, and controversy over identifiable treatment targets will continue until distinct pathophysiological mechanism of vascular dementia is found. Clinical diagnostic criteria are sufficiently strong to be useful for clinical trials, but need further refinement. Cognitive changes in vascular dementia are more variable than other disorders, and are dependent on the vascular pathology. Accurate diagnosis of vascular dementia is known to need the presence of reliable cerebrovascular disease on brain imaging. Although it seems obvious that cerebrovascular disease causes pathological damage and impaired cognition, it is very difficult to find the accurate contribution of cerebrovascular pathology to cognitive decline. Most studies have shown a small but significant benefit of cholinesterase inhibitors on cognition, the significance of this effect has been slight and benefits on global functioning, activities of daily living, and behaviour have not been consistently reported. Management of vascular dementia should focus on identifying and managing vascular risk factors.

• Natural Product Sciences
• /
• v.18 no.4
• /
• pp.233-238
• /
• 2012

Nine compounds (1 - 9), ${\alpha}$-linolenic acid (1), cis-5,8,11,14,17-elcosapentaenoic acid (2), phytol (3), loliolide (4), uridine (5), thymidine (6), deoxyadenosine (7), adenine (8), and adenosine (9), were isolated from the n-hexane, methylene chloride, ethyl acetate and n-butanol fractions of Capsosiphon fulvescens. The structures of these compounds were elucidated on the basis of spectroscopic evidence. Compounds 1 - 9 exhibited acetylcholinesterase (AChE) inhibitory activities with $IC_{50}$ values ranging from 114.91 to $252.40{\mu}M$, whereas 2 - 4 showed butyrylcholinesterase (BChE) inhibitory activities with $IC_{50}$ values ranging from 251.18 to $499.16{\mu}M$.

• Journal of the Korean Society of Tobacco Science
• /
• v.20 no.1
• /
• pp.80-86
• /
• 1998

Changes in activity and classification of esterase isozymes during the tire cycle or Plodia inteipunctella (Hiibner) were investigated by the native polyacrylamide gel electrophoresis. The stage specificity in esterase activity and isozyme pattern was observed throughout the larvalpupal-adult transformation. The activity esterase was highest at the 3-day old adult stage, and the lowest level at the prepupal stage. A total of 12 esterase bands were identified throughout the development, and the bands showing high enzyme activity was observed in the middle part of gel. Twelve esterases on the basis of inhibition by the three types of inhibitors (organophosphates, eserine sulfate and sulfhydryl reagents) were classified into three class, namely, carboxylesterase (CE), arylesterase (ArE) and cholinesterase (ChE), and these classes contained 7, 3 and 2 isozymes, respectively.

• Toxicological Research
• /
• v.4 no.2
• /
• pp.107-115
• /
• 1988

The effects of altering the hepatic mixed-function oxidase(MFO) activities on the acute toxicity of parathion were examined in female rats. Phenobarbital sodium pretreatment (50mg/kg/day, i.p.) for 4 consecutive days has resulted in significant decreases in the toxicity of parathion (2 or 4 mg/kg, i.p.) as determined by lethality and cholinesterase activities wheras the toxicity arising from a single dose of CCl4(2 mmol/kg, i.p.) 24 hr prior to parathion challenge was potentiated.

• Toxicological Research
• /
• v.4 no.2
• /
• pp.85-94
• /
• 1988

In order to elucidate the mechanism of toxic action of a pisonous mushroom, Amanita pantherina, biochemical effects of the mushroom extracts on mice were studied. A hotwater extract of Amanita pantherina injected intraperitoneally into male ICR mice evoked signs similar to those observed clinically upon acute poisoning by the mushroom and also changed the levels of component enzyme activities in blood, liver and urine. The serum cholinesterase activity was decreased significantly during 1-3 h after injection.

• Proceedings of the Korean Society of Applied Pharmacology
• /
• 1995.04a
• /
• pp.45-46
• /
• 1995

Alzheimer's disease is believed to be associated with the loss of cholinergic activity in the cortex and hippocampus. In addition, it has been reported that the monoaminergic systems which also controls brain functions are disturbed in Alzheimer's patients. Based on these neurochemical background, a number of cholinesterase inhibitors including tacrine and its analogues and some monoamine oxidase inhibitors such as L-deprenyl and monoamine reuptake inhibitors have been developed for the treatment of dementia, but all of the known drugs are not truly effective. We thought that a drug that activates only one neurotransmitter system is not effective enough for the treatment of the symptoms associated with Alzheimer's disease and vascular dementia, and we conceived that an agent enhancing both central cholinergic and monoaminergic functions would be useful for the treatment of dementia

• Proceedings of the Korean Society of Applied Pharmacology
• /
• 1995.04a
• /
• pp.111-111
• /
• 1995

1. 혈압 및 맥박 실험 Acetylcholine과 상엽 수층분획을 단독으로 정맥에 투여한 경우 각각에서 농도 의존적으로 일시적인 혈압 강하 효과가 나타났고 빈맥 현상이 관찰되었다. Nitric Oxide 합성효소 억제제인 N$^{G}$ -Nitro-L-Arginine Methyl Ester(10 mg/kg I. v)를 전처리한 경우 위 두 약물에 의한 혈압강하효과는 공히 증가되어졌다. 또한 두 약물에 의한 혈압강하 효과는 Atropine Sulfate(1 mg/kg i.v) 전처리로 완전히 차단되었다. Cholinesterase 억제제인 Physostigmine (0.05 mg/kg i.v) 전처리는 상엽의 혈압강하 효과에 아무런 영향을 나타내지 못하였다. 2. 장관 실험 Acetylcholine과 상엽 수층분획을 organ bath에 첨가한 경우 각각에서 농도 의존적으로 장관 수축력을 증가시켰다. 혈압반응에서와 같이 장관실험에서도 두 약물에 의한 장관 수축력의 증가는 Atropine Sulfate(1$\times$$10^{-5}$ M)의 존재하에서는 완전히 차단되어졌다. 이상의 결과로부터 상엽 수층분획은 Acetylcholine과 유사한 작용을 지닌 물질을 함유하는 것으로 사료된다.

• Journal of Chest Surgery
• /
• v.34 no.8
• /
• pp.634-639
• /
• 2001

Central anticholinergic syndrome is defined as an absolute or relative reduction in cholinergic activity in the central nervous system and has a wide variety of manfestations. It is associated with almost any drug given during anesthesia, except neuromuscular relaxants, and treated with the cholinesterase inhibitor physostigmine. The diagnosis of central anticholinergic syndrome is often made when symptoms resolve promptly after the administration of physostigmine. We present a case of a central anticholinergic syndrome diagnosed by treatment with physostigmine, in a patient who received closure of patent foramen ovale associated with stroke.

• Molecular & Cellular Toxicology
• /
• v.2 no.3
• /
• pp.216-221
• /
• 2006

The cholinesterase-inhibiting organophosphorous (OP) compounds known as nerve agents are highly toxic. The principal toxic mechanism of OP compounds is the inhibition of acethylcholine esterase (AChE) by phosphorylation of its catalytic site. The reversible competitive inhibition of AChE may prevent the subsequent OP intoxication. In this study, three-dimensional quantitative structure-activity relationship (3D-QSAR) was performed to investigate the relationship between the 29 compounds with structural diversity and their bioactivities against AChE. In particular, predictive models were constructed using the comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA). The results indicate reasonable model for CoMFA ($q^{2}=0.453,\;r^{2}=0.697$) and CoMSIA ($q^{2}=0.518,\;r^{2}=0.696$). The presence of steric and hydophobic group at naphtyl moiety of the model may lead to the design of improved competitive inhibitors for organophosphorous intoxication.

• Bulletin of the Korean Chemical Society
• /
• v.35 no.2
• /
• pp.655-658
• /
• 2014